Skip to content

Clinical trials

Bipolar Disorder trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20071
20091
20182
20201
20221
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Recruiting2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center2
AstraZeneca1
Eli Lilly and Company1
GH Research Ireland Limited1
Geestelijke Gezondheidszorg Eindhoven (GGzE)1
GlaxoSmithKline1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Leiden University Medical Center1
Ludwig-Maximilians - University of Munich1
Maastricht University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder14
Schizophrenia4
Depressive Disorder2
Autistic Disorder1
Diabetes Insipidus, Nephrogenic1
Major Depressive Disorder1
Mental Disorders1
Prodromal Symptoms1
Psychotic Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.